视神经脊髓炎谱系疾病-话题@MedSci

#视神经脊髓炎谱系疾病#

8篇内容 | 1092人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2200133, encodeId=71842200133a8, content=<a href='/topic/show?id=0a0b5496306' target=_blank style='color:#2F92EE;'>#抑郁#</a> <a href='/topic/show?id=87206e28215' target=_blank style='color:#2F92EE;'>#焦虑#</a> <a href='/topic/show?id=e30d90e23cf' target=_blank style='color:#2F92EE;'>#视神经脊髓炎谱系疾病#</a> <a href='/topic/show?id=880711366222' target=_blank style='color:#2F92EE;'>#AAN 2024#</a>, objectTitle=AAN 2024：视神经脊髓炎谱系疾病患者抑郁和焦虑研究：来自美国数据集分析结果, objectType=article, longId=823089, objectId=e09182308977, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240422/1713799945407_8624274.png, objectUrl=/article/show_article.do?id=e09182308977, replyNumber=0, likeNumber=8, createdTime=2024-04-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e09182308977, moduleTitle=AAN 2024：视神经脊髓炎谱系疾病患者抑郁和焦虑研究：来自美国数据集分析结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e09182308977)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2175927, encodeId=b39121e5927ba, content=<a href='/topic/show?id=e30d90e23cf' target=_blank style='color:#2F92EE;'>#视神经脊髓炎谱系疾病#</a> <a href='/topic/show?id=7f03e60980e' target=_blank style='color:#2F92EE;'>#米托蒽醌#</a>, objectTitle=NNN：米托蒽醌治疗视神经脊髓炎谱系疾病的大型多中心队列研究, objectType=article, longId=805952, objectId=5960805952ee, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/multiple-sclerosis-s13-mri-brain-and-spinal-cord.jpg, objectUrl=/article/show_article.do?id=5960805952ee, replyNumber=0, likeNumber=36, createdTime=2023-12-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=5960805952ee, moduleTitle=NNN：米托蒽醌治疗视神经脊髓炎谱系疾病的大型多中心队列研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5960805952ee)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2175928, encodeId=70fa21e5928f1, content=<a href='/topic/show?id=e30d90e23cf' target=_blank style='color:#2F92EE;'>#视神经脊髓炎谱系疾病#</a> <a href='/topic/show?id=7fea105824ba' target=_blank style='color:#2F92EE;'>#MOGAD#</a>, objectTitle=NNN：MOG-IgG 检测的时机是 2023 年 MOGAD 诊断标准的关键, objectType=article, longId=805951, objectId=59f08059514f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/267914-eye.jpg, objectUrl=/article/show_article.do?id=59f08059514f, replyNumber=0, likeNumber=38, createdTime=2023-12-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=59f08059514f, moduleTitle=NNN：MOG-IgG 检测的时机是 2023 年 MOGAD 诊断标准的关键, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59f08059514f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2124109, encodeId=e03f212410934, content=长效<a href='/topic/show?id=c59110582225' target=_blank style='color:#2F92EE;'>#补体C5蛋白抑制剂#</a><a href='/topic/show?id=d17e1515814' target=_blank style='color:#2F92EE;'>#ravulizumab#</a>能降低<a href='/topic/show?id=ea7810582164' target=_blank style='color:#2F92EE;'>#AQP4#</a>抗体阳性的<a href='/topic/show?id=e30d90e23cf' target=_blank style='color:#2F92EE;'>#视神经脊髓炎谱系疾病#</a>患者的复发风险降低98.6%, objectTitle=长效补体C5蛋白抑制剂ravulizumab能降低AQP4抗体阳性的NMOSD患者的复发风险降低98.6%, objectType=article, longId=745354, objectId=db70e45354bb, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20221027/e11ac154aeb74a5c861b133a828adb92.jpg, objectUrl=/article/show_article.do?id=db70e45354bb, replyNumber=0, likeNumber=48, createdTime=2023-04-06, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=db70e45354bb, moduleTitle=长效补体C5蛋白抑制剂ravulizumab能降低AQP4抗体阳性的NMOSD患者的复发风险降低98.6%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db70e45354bb)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=1202411, encodeId=2ada1202411b8, content=<a href='/topic/show?id=e30d90e23cf' target=_blank style='color:#2F92EE;'>#视神经脊髓炎谱系疾病#</a>这个药，在国内是瀚森制药在卖了，终于<a href='/topic/show?id=93f4128920b' target=_blank style='color:#2F92EE;'>#NMPA#</a>也批准了, objectTitle=Lancet：Inebilizumab可降低视神经脊髓炎谱系疾病 (NMOSD)发作风险, objectType=article, longId=179047, objectId=b78a1e90479f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/webeditor/uploadfile/201909/20190906182455771.jpg, objectUrl=/article/show_article.do?id=b78a1e90479f, replyNumber=0, likeNumber=85, createdTime=2022-03-14, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b78a1e90479f, moduleTitle=Lancet：Inebilizumab可降低视神经脊髓炎谱系疾病 (NMOSD)发作风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b78a1e90479f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1202410, encodeId=0f93120241027, content=<a href='/topic/show?id=e30d90e23cf' target=_blank style='color:#2F92EE;'>#视神经脊髓炎谱系疾病#</a>, objectTitle=NEJM：Eculizumab治疗可降低AQP4-IgG阳性的NMOSD患者复发风险, objectType=article, longId=177729, objectId=e7ca1e77290c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/webeditor/uploadfile/201908/20190815184920479.jpg, objectUrl=/article/show_article.do?id=e7ca1e77290c, replyNumber=0, likeNumber=78, createdTime=2022-03-14, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e7ca1e77290c, moduleTitle=NEJM：Eculizumab治疗可降低AQP4-IgG阳性的NMOSD患者复发风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e7ca1e77290c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1202409, encodeId=26631202409ad, content=<a href='/topic/show?id=e30d90e23cf' target=_blank style='color:#2F92EE;'>#视神经脊髓炎谱系疾病#</a>, objectTitle=NEJM：Satralizumab治疗视神经脊髓炎谱系疾病的SAkuraSky III期研究取得喜人结果, objectType=article, longId=183902, objectId=8908183902b8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/webeditor/uploadfile/201911/20191130211911139.jpeg, objectUrl=/article/show_article.do?id=8908183902b8, replyNumber=0, likeNumber=71, createdTime=2022-03-14, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8908183902b8, moduleTitle=NEJM：Satralizumab治疗视神经脊髓炎谱系疾病的SAkuraSky III期研究取得喜人结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8908183902b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1202408, encodeId=8fc91202408c7, content=<a href='/topic/show?id=e30d90e23cf' target=_blank style='color:#2F92EE;'>#视神经脊髓炎谱系疾病#</a>, objectTitle=JNNP：视神经脊髓炎谱系疾病：与妊娠有关的发作和预测危险因素, objectType=article, longId=203865, objectId=e7a2203865f8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201129/1606614530712_2026338.gif, objectUrl=/article/show_article.do?id=e7a2203865f8, replyNumber=0, likeNumber=76, createdTime=2022-03-14, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e7a2203865f8, moduleTitle=JNNP：视神经脊髓炎谱系疾病：与妊娠有关的发作和预测危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e7a2203865f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1202407, encodeId=4c68120240ed8, content=<a href='/topic/show?id=e30d90e23cf' target=_blank style='color:#2F92EE;'>#视神经脊髓炎谱系疾病#</a>终于有治疗药物了, objectTitle=NMPA批准Uplizna(伊奈利珠单抗)治疗视神经脊髓炎谱系疾病(NMOSD), objectType=article, longId=300728, objectId=859d300e2836, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20220311/389343f98fe94e3d8b856f9bdbb2edcc.jpg, objectUrl=/article/show_article.do?id=859d300e2836, replyNumber=0, likeNumber=88, createdTime=2022-03-14, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=859d300e2836, moduleTitle=NMPA批准Uplizna(伊奈利珠单抗)治疗视神经脊髓炎谱系疾病(NMOSD), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=859d300e2836)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1202406, encodeId=e52a1202406df, content=<a href='/topic/show?id=e30d90e23cf' target=_blank style='color:#2F92EE;'>#视神经脊髓炎谱系疾病#</a>, objectTitle=Radiology：视神经脊髓炎谱系疾病的新角度：从影像走向临床, objectType=article, longId=214486, objectId=adba21448651, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021720/1626749864767_1605392.png, objectUrl=/article/show_article.do?id=adba21448651, replyNumber=0, likeNumber=59, createdTime=2022-03-14, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=adba21448651, moduleTitle=Radiology：视神经脊髓炎谱系疾病的新角度：从影像走向临床, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=adba21448651)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1202405, encodeId=0fe6120240577, content=<a href='/topic/show?id=e30d90e23cf' target=_blank style='color:#2F92EE;'>#视神经脊髓炎谱系疾病#</a>有药物了, objectTitle=中国视神经脊髓炎谱系疾病诊断与治疗指南(2021版), objectType=guider, longId=15941, objectId=5639f1c002330240, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=5639f1c002330240, replyNumber=0, likeNumber=107, createdTime=2022-03-14, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5639f1c002330240, moduleTitle=中国视神经脊髓炎谱系疾病诊断与治疗指南(2021版), moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=5639f1c002330240)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

视神经脊髓炎谱系疾病

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#抑郁# #焦虑# #视神经脊髓炎谱系疾病# #AAN 2024#

AAN 2024：视神经脊髓炎谱系疾病患者抑郁和焦虑研究：来自美国数据集分析结果

2024-04-24发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#视神经脊髓炎谱系疾病# #米托蒽醌#

NNN：米托蒽醌治疗视神经脊髓炎谱系疾病的大型多中心队列研究

2023-12-19发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#视神经脊髓炎谱系疾病# #MOGAD#

NNN：MOG-IgG 检测的时机是 2023 年 MOGAD 诊断标准的关键

2023-12-19发表于上海

(审核中...)

前往app查看评论内容

长效#补体C5蛋白抑制剂##ravulizumab#能降低#AQP4#抗体阳性的#视神经脊髓炎谱系疾病#患者的复发风险降低98.6%

长效补体C5蛋白抑制剂ravulizumab能降低AQP4抗体阳性的NMOSD患者的复发风险降低98.6%

2023-04-06发表于上海

医者仁者 (审核中...)

前往app查看评论内容

#视神经脊髓炎谱系疾病#这个药，在国内是瀚森制药在卖了，终于#NMPA#也批准了

Lancet：Inebilizumab可降低视神经脊髓炎谱系疾病 (NMOSD)发作风险

2022-03-14

医者仁者 (审核中...)

前往app查看评论内容

#视神经脊髓炎谱系疾病#

NEJM：Eculizumab治疗可降低AQP4-IgG阳性的NMOSD患者复发风险

2022-03-14

医者仁者 (审核中...)

前往app查看评论内容

#视神经脊髓炎谱系疾病#

NEJM：Satralizumab治疗视神经脊髓炎谱系疾病的SAkuraSky III期研究取得喜人结果

2022-03-14

医者仁者 (审核中...)

前往app查看评论内容

#视神经脊髓炎谱系疾病#

JNNP：视神经脊髓炎谱系疾病：与妊娠有关的发作和预测危险因素

2022-03-14

医者仁者 (审核中...)

前往app查看评论内容

#视神经脊髓炎谱系疾病#终于有治疗药物了

NMPA批准Uplizna(伊奈利珠单抗)治疗视神经脊髓炎谱系疾病(NMOSD)

2022-03-14

医者仁者 (审核中...)

前往app查看评论内容

#视神经脊髓炎谱系疾病#

Radiology：视神经脊髓炎谱系疾病的新角度：从影像走向临床

2022-03-14

医者仁者 (审核中...)

前往app查看评论内容

#视神经脊髓炎谱系疾病#有药物了

中国视神经脊髓炎谱系疾病诊断与治疗指南(2021版)

2022-03-14

科室
- - 订阅+
  - 更多科室
工具
服务